Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV
Authors:
- Denis PuthierDenis Puthier
- Victor AppayVAVictor Appay
- Olivier PelléOPOlivier Pellé
- Hocine Ait-MohandHAHocine Ait-Mohand
- Béhazine CombadièreBCBéhazine Combadière
- Ghislaine CarcelainGCGhislaine Carcelain
- Christine KatlamaCKChristine Katlama
- Sarah L Rowland-JonesSRSarah L Rowland-Jones
- Patrice DebréPDPatrice Debré
- Catherine NguyenCNCatherine Nguyen
- Brigitte AutranBABrigitte Autran
- 18 November 2005
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 19 (17) , 1981-1986
Abstract
To further understand differentiation and homeostasis of CD8 T cells specific for HIV, Epstein–Barr Virus (EBV) and cytomegalovirus (CMV) during HIV infection, we investigated interleukin-7 receptor α (IL-7Rα) expression on those virus-specific T cells. Microarrays and cytometry analyses were performed on peripheral blood mononuclear cells (PBMC), total and tetramer-binding virus-specific CD8 T cells from 66 HIV-infected patients. Microarray analysis revealed reduced levels of IL-7Rα and increased levels of perforin with disease progression in total PBMC. This loss of IL-7Rα expression was observed on CD8 T cells and was inversely related to perforin expression. The relative expression of both molecules defined three new subsets: IL-7RαposPerforinneg; IL-7RαlonegPerforinlo; and IL-7RαlonegPerforinhi corresponding to naive and effector-memory CD8 differentiation, as assessed by CD45RA/CD11a. The IL-7Rα expression decreased along the CD8 differentiation pathway defined by CD27 and CD28. In contrast, IL-7Rα expression was down-modulated on all the CD8 T cells specific for HIV, EBV and CMV that were almost exclusively IL-7Rαlo/negPerforinlo and was parallel with the CD27 expression. In addition, this low IL-7Rα expression on HIV-specific CD8 T cells was independent of virus load and T-cell activation and remained stable during the first 6 months of antiretroviral therapy despite successful control of HIV replication. The relative expression of IL-7Rα, perforin reveals new aspects of virus-specific CD8 T cell differentiation, independently of T-cell activation and virus load. This opens new perspectives for understanding homeostasis of those cells and immune-based therapeutic strategies.Keywords
This publication has 22 references indexed in Scilit:
- CD7 Is a Differentiation Marker That Identifies Multiple CD8 T Cell Effector SubsetsThe Journal of Immunology, 2003
- Molecular and Functional Profiling of Memory CD8 T Cell DifferentiationCell, 2002
- Lack of Epstein-Barr virus- and HIV-specific CD27− CD8+ T cells is associated with progression to viral disease in HIV-infectionAIDS, 2002
- Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infectionsNature Medicine, 2002
- Skewed maturation of memory HIV-specific CD8 T lymphocytesNature, 2001
- Dynamics of HIV-Specific CD8+ T Lymphocytes with Changes in Viral LoadThe Journal of Immunology, 2000
- HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic FunctionJournal of Experimental Medicine, 2000
- Sensitivity Issues in DNA Array-Based Expression Measurements and Performance of Nylon Microarrays for Small SamplesHuman Molecular Genetics, 1999
- CD8hi+CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activityInternational Immunology, 1998
- Differential Gene Expression in the Murine Thymus Assayed by Quantitative Hybridization of Arrayed cDNA ClonesGenomics, 1995